Ethiqa XR® Broached Vial Usage Extended to 90 Days
Fidelis Pharmaceuticals, the company that produces Ethiqa XR®, the first FDA-indexed extended-release buprenorphine formulation specifically for mice and rats, recently announced a change to the drug’s storage requirements. After extensive in-house studies and testing to collect sufficient efficacy data, the company has extended the drug’s storage and use to 90 days post vial broach. Previously, ...











